Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

40 results about "Anetoderma" patented technology

Anetoderma is a localized laxity of the skin with herniation or outpouching resulting from abnormal dermal elastic tissue.

Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation

The present disclosure relates, in one aspect, to use of ghrelin splice variant or an analogue thereof for the preparation of a medicament for one or more of: treatment and / or prevention of loss of body weight and body fat, prophylaxis or treatment of cachexia, stimulation of appetite, stimulation of food intake, stimulation of weight gain, or increasing body fat mass, or increasing body lean mass. Another aspect relates to the use of a ghrelin splice variant-like compound for the preparation of a medicament for the prophylaxis or treatment of cancer cachexia in an individual in need of such treatment. Another aspect relates to the use of a ghrelin splice variant-like compound for the preparation of a medicament for prophylaxis or treatment of cachexia in an individual by administering a subcutaneous dosage of said medicament to the individual. A further aspect relates to the use of a ghrelin splice variant-like compound or a pharmaceutically acceptable salt thereof for the preparation of a medicament for stimulation of appetite in an individual by administering a subcutaneous dosage of said medicament to the individual. A further aspect relates to a number of new ghrelin splice variant-like compounds and uses thereof, as well as to pharmaceutical compositions and medical packaging comprising the new ghrelin splice variant-like compounds.
Owner:MINTZ LIAT

Traditional Chinese medicinal composition for treating children anorexia as well as preparation method and application of traditional Chinese medicinal composition

The invention provides a traditional Chinese medicinal composition for treating children anorexia. The traditional Chinese medicinal composition mainly consists of the following medicinal raw materials: white hyacinth bean, Chinese yam, poria cocos, dark plum, concha ostreae, fructus citri sarcodactyli, fructus hordei germinatus, semen ziziphi spinosae, fructus ziziphi jujubae, arillus longan, fructus alpiniae oxyphyllae, mulberry, fructus crataegi and semen raphani. Furthermore, the traditional Chinese medicinal composition consists of the following medicinal raw materials (in parts by weight): 3-15 parts of white hyacinth bean, 1-10 parts of Chinese yam, 3-15 parts of poria cocos, 1-8 parts of dark plum, 1-8 parts of concha ostreae, 1-8 parts of fructus citri sarcodactyli, 1-8 parts of fructus hordei germinatus, 3-15 parts of semen ziziphi spinosae, 1-8 parts of fructus ziziphi jujubae, 1-8 parts of arillus longan, 1-8 parts of fructus alpiniae oxyphyllae, 1-8 parts of mulberry, 1-8 parts of fructus crataegi and 1-10 parts of semen raphani. The composition disclosed by the invention has functions of tonifying stomach and spleen, boosting immunity and activity of children, tonifying brain and improving intelligence, and the like.
Owner:ZHEJIANG ASEN PHARMA

Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation

The present disclosure relates, in one aspect, to use of ghrelin splice variant or an analogue thereof for the preparation of a medicament for one or more of: treatment and / or prevention of loss of body weight and body fat, prophylaxis or treatment of cachexia, stimulation of appetite, stimulation of food intake, stimulation of weight gain, or increasing body fat mass, or increasing body lean mass. Another aspect relates to the use of a ghrelin splice variant-like compound for the preparation of a medicament for the prophylaxis or treatment of cancer cachexia in an individual in need of such treatment. Another aspect relates to the use of a ghrelin splice variant-like compound for the preparation of a medicament for prophylaxis or treatment of cachexia in an individual by administering a subcutaneous dosage of said medicament to the individual. A further aspect relates to the use of a ghrelin splice variant-like compound or a pharmaceutically acceptable salt thereof for the preparation of a medicament for stimulation of appetite in an individual by administering a subcutaneous dosage of said medicament to the individual. A further aspect relates to a number of new ghrelin splice variant-like compounds and uses thereof, as well as to pharmaceutical compositions and medical packaging comprising the new ghrelin splice variant-like compounds.
Owner:MINTZ LIAT

Use of Ghrelin Splice Variant for Treating Cachexia and/or Anorexia and/or Anorexia-Cachexia and/or Malnutrition and/or Lipodystrophy and/or Muscle Wasting and/or Appetite-Stimulation

The present disclosure relates, in one aspect, to use of ghrelin splice variant or an analogue thereof for the preparation of a medicament for one or more of: treatment and / or prevention of loss of body weight and body fat, prophylaxis or treatment of cachexia, stimulation of appetite, stimulation of food intake, stimulation of weight gain, or increasing body fat mass, or increasing body lean mass. Another aspect relates to the use of a ghrelin splice variant-like compound for the preparation of a medicament for the prophylaxis or treatment of cancer cachexia in an individual in need of such treatment. Another aspect relates to the use of a ghrelin splice variant-like compound for the preparation of a medicament for prophylaxis or treatment of cachexia in an individual by administering a subcutaneous dosage of said medicament to the individual. A further aspect relates to the use of a ghrelin splice variant-like compound or a pharmaceutically acceptable salt thereof for the preparation of a medicament for stimulation of appetite in an individual by administering a subcutaneous dosage of said medicament to the individual. A further aspect relates to a number of new ghrelin splice variant-like compounds and uses thereof, as well as to pharmaceutical compositions and medical packaging comprising the new ghrelin splice variant-like compounds.
Owner:MINTZ LIAT

Traditional Chinese medicine composition for treating child anorexia and preparation method of traditional Chinese medicine composition for treating child anorexia

The invention relates to a traditional Chinese medicine composition for treating child anorexia and a preparation method of the traditional Chinese medicine composition for treating child anorexia. The traditional Chinese medicine composition is prepared from 12 kinds of raw material medicine materials of radix codonopsis, bighead atractylodes rhizomes, radix ophiopogonis, polygonatum odoratum, herba dendrobii, haws, white peony roots, dried orange peel, Chinese yams, endothelium corneum gigeriae galli, striga asiatica and licorice roots through technologies of performing pretreatment, performing decoction, performing ethanol precipitation, performing concentration, performing drying and the like. The traditional Chinese medicine composition has the efficacy of benefitting qi, invigoratingthe spleen, nourishing yin, nourishing the stomach and resolving food stagnation, and is used for diseases of anorexia or apastia caused by infantile deficiency and weakness of spleen qi and defectsof stomach yin, lack of lustre in complexion, loss of spirit, emaciated or puffy bodies, easiness to sweat, loose stool or constipation, or retention of food and drink, abdominal fullness and distention and the like. The animal experiment result indicates that the traditional Chinese medicine composition disclosed by the invention can increase the food intake of an anorexia model bandicoot, can promote secretion of gastrin of the gastric antrum part, can achieve the effect of treating both manifestation and root cause of the child anorexia, and has great broad market development prospects.
Owner:LUNAN PHARMA GROUP CORPORATION

Traditional Chinese medicine composition for treating child food dyspepsia spleen deficiency type anorexia and application of traditional Chinese medicine composition

InactiveCN110420300APromote osmotic absorptionBe kind to the stale product of wine and foodDigestive systemPlant ingredientsSide effectMassage
The invention discloses a traditional Chinese medicine composition for treating child food dyspepsia spleen deficiency type anorexia and application of the traditional Chinese medicine composition. The traditional Chinese medicine composition for treating the child food dyspepsia spleen deficiency type anorexia is prepared from the following bulk pharmaceutical chemicals in parts by weight: 30-60parts of fructus crataegi, 10-30 parts of medicated leaven, 15-35 parts of fructus hordei germinatus, 10-30 parts of pericarpium citri reticulatae, 20-40 parts of poria cocos and 15-40 parts of rhizome atractylodis macrocephalae, a dosage form of the traditional Chinese medicine composition is an external use dosage form, the an external use dosage form is an ointment, an aerosol, a spray or a linimentum, and the traditional Chinese medicine composition is used as an external medium in the medical massage process. The traditional Chinese medicine composition has functions of promoting digestion to eliminate stagnation and strengthening spleen to transport and clearing damp, and can be used for treating the child food dyspepsia spleen deficiency type anorexia. The traditional Chinese medicine composition for treating child food dyspepsia spleen deficiency type anorexia has the advantages that the traditional Chinese medicine composition is used as the medium for external use for treating the child food dyspepsia spleen deficiency type anorexia in a medical massage mode, the therapeutic effect is very remarkable, the traditional Chinese medicine composition is safe to human bodies, and no side effect exists.
Owner:慈幼(上海)健康管理咨询有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products